The MYC family of transcription factors (MYC, MYCN, L-MYC) serves as pivotal oncogenic drivers in neuroendocrine tumors, such as cancers of the lung, pancreas, gastrointestinal tract, prostate, and NB 36. Here, MYC is linked to neuroendocrine neoplasm.